Who is sponsoring NCT02404285?

NCT02404285 is sponsored by Next Science TM.

What condition does NCT02404285 study?

NCT02404285 studies Acne Vulgaris.

What drugs are being tested in NCT02404285?

Interventions: Next Science Acne Gel, Vehicle.

What is the status of NCT02404285?

NCT02404285 is currently COMPLETED.

Last reviewed 2023-11-05 · How we verify

A Multi-center, Double-blind, Vehicle-controlled Study to Evaluate the Clinical Effect of Daily Next Science™ Acne Gel (NAG) on Mild to Moderate Facial Acne

NCT02404285 Phase 1/Phase 2 COMPLETED Results posted

This is a 12 week, multi-site, double-blind, vehicle-controlled study in subjects with mild to moderate facial acne. Subjects will be randomized 1:1 to apply either topical NAG or vehicle gel daily. Subjects will be evaluated for clinical acne and quality of life outcomes at baseline, 2 weeks, 4 weeks, 8 weeks and 12 weeks.

Details

Lead sponsor	Next Science TM
Phase	Phase 1/Phase 2
Status	COMPLETED
Enrolment	68
Start date	2015-03
Completion	2015-09

Conditions

Acne Vulgaris

Interventions

Next Science Acne Gel
Vehicle

Primary outcomes

Change in Inflammatory Lesions With Daily Use of NAG Compared With Vehicle After 12-weeks of Use. — Baseline until 12 weeks
Percent change in number of Inflammatory lesions with daily use of NAG compared with vehicle after 12-weeks of use.

Countries

United States